Jeffrey Ross's most recent trade in Miromatrix Medical Inc was a trade of 31,250 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on March 10, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Miromatrix Medical Inc | Jeffrey Ross | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 10 Mar 2023 | 31,250 | 396,276 | - | 1.6 | 50,000 | Common Stock |
Miromatrix Medical Inc | Jeffrey Ross | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
Miromatrix Medical Inc | Jeffrey Ross | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 50,000 | 369,513 | - | 0 | Common Stock | |
Miromatrix Medical Inc | Jeffrey Ross | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.26 per share. | 13 Jan 2023 | 4,487 | 365,026 | - | 3.3 | 14,628 | Common Stock |
Miromatrix Medical Inc | Jeffrey Ross | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2022 | 37,500 | 0 | - | - | Employee Stock Option (right to buy) | |
Miromatrix Medical Inc | Jeffrey Ross | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.25 per share. | 06 Dec 2022 | 37,500 | 331,088 | - | 1.3 | 46,875 | Common Stock |
Miromatrix Medical Inc | Jeffrey Ross | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. | 06 Dec 2022 | 11,575 | 319,513 | - | 4.1 | 46,879 | Common Stock |
Miromatrix Medical Inc | Jeffrey Ross | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.25 per share. | 15 Mar 2022 | 35,438 | 293,588 | - | 1.3 | 44,298 | Common Stock |
Miromatrix Medical Inc | Jeffrey Ross | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 35,438 | 0 | - | - | Employee Stock Option (right to buy) |